Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Journal of the American Academy of Dermatology|December 28, 2006
Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2)Julia E Graves, Kara Nunley, Michael P HeffernanJournal of the American Academy of Dermatology|July 18, 2006
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinibJulia E Graves, Beverly F Jones, Anne C Lind, et al.Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Off-label uses of biologic agents in dermatology: a 2006 updateMary Jo J Kerns, Julia E Graves, David I Smith, et al.Journal of Drugs in Dermatology : JDD|March 22, 2007
A single-center, open-label, prospective pilot study of subcutaneous efalizumab for oral erosive lichen planusMichael P Heffernan, David I Smith, Danette Bentley, et al.Archives of Dermatology|April 19, 2006
Skin cancer examination teaching in US medical educationMegan M Moore, Alan C Geller, Zi Zhang, et al.Pageof 1